Antibiotic Susceptibility and Resistance Patterns of Staphylococcus aureus Isolated from Pus Samples in Tobruk Medical Center at Tobruk, Libya

• Fatalla Merjan Daboos

  Faculty of Medical Technology, Tobruk University, Tobruk, Libya.

  Author

• Eisa S Omar

  Department of Microbiology, Faculty of Medicine, University of Tobruk, Tobruk, Libya.

  Author

• Osama Muftah Ahmed

  Faculty of Medical Technology, Tobruk University, Tobruk, Libya

  Author

Staphylococcus aureus is a leading cause of purulent infections worldwide, with rising concerns about antibiotic resistance, particularly methicillin-resistant S. aureus (MRSA). This study aimed to determine the prevalence and antimicrobial susceptibility patterns of S. aureus isolated from pus samples at Tobruk Medical Center, Libya. Methods: A total of 127 pus samples were collected from patients with suspected S. aureus infections between April and December 2023. Specimens were cultured on Blood and Mannitol Salt agars. S. aureus isolates were identified using standard microbiological techniques (Gram stain, catalase, and coagulase tests). Antimicrobial susceptibility testing was performed against nine antibiotics (Levofloxacin, Clindamycin, Gentamicin, Doxycycline, Erythromycin, Penicillin, Ciprofloxacin, Cefoxitin, and Tetracycline) using the Kirby-Bauer disk diffusion method, following CLSI guidelines. Results: Out of 127 samples, 60 (47.2%) were culture-positive for S. aureus. The isolates exhibited high resistance rates to Penicillin (62.82%) and Erythromycin (58.97%). Cefoxitin disc testing identified a high prevalence of MRSA at 53.84%. In contrast, the highest susceptibility was observed to Gentamicin (57.69%), Ciprofloxacin (57.69%), and Doxycycline (51.28%). Levofloxacin also showed good activity with a susceptibility rate of 48.71%. Conclusion: This study reveals an alarmingly high prevalence of MRSA and multidrug-resistant S. aureus in pus isolates from our setting. Penicillin and Erythromycin are ineffective as empirical treatments. Gentamicin, Ciprofloxacin, and Doxycycline retained higher efficacy. These findings underscore the critical need for continuous antimicrobial resistance surveillance and stringent antibiotic stewardship policies to guide effective treatment and control the spread of resistant strains in Tobruk, Libya

Abdullahi, A., Amenu, D., Zekarias, A., Tsegaye, Y., & Stranges, N. (2022). The burden of methicillin-resistant Staphylococcus aureus (MRSA) in Africa: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance, 29, 543 552. https://doi.org/10.1016/j.jgar.2022.05.001 DOI: https://doi.org/10.1016/j.jgar.2022.05.001

Al-Hamad, A. M., Alfaraj, A. A., Altowaileb, J., Alrayyan, N., Althaqib, M., Alsubikhi, F., & Bosaeed, M. (2021). Prevalence and molecular characteristics of methicillin resistant Staphylococcus aureus (MRSA) among patients with diabetic foot infection in a tertiary care hospital in Saudi Arabia. Journal of Infection and Public Health, 14(7), 905–910. https://doi.org/10.1016/j.jiph.2021.04.012 DOI: https://doi.org/10.1016/j.jiph.2021.04.012

Dengler Haumeiter, L., Böhm, S., Kamenšek, S., & Zinkernagel, A. S. (2024). Staphylococcus aureus promotes its survival in neutrophils by triggering autophagy-dependent neutrophil extracellular trap formation. PLoS Pathogens, 20(1), e1011923. https://doi.org/10.1371/journal.ppat.1011923 DOI: https://doi.org/10.1371/journal.ppat.1011923

Elahmer, O., Siala, M., Ghenghesh, K. S., & Berbash, N. (2017). Antibiotic resistance in bacteria isolated from common infections in Libyan children. Journal of Infection in Developing Countries, 11(4), 339–346. https://doi.org/10.3855/jidc.8183

Gonzalez, C. D., Acker, K. P., & Torres, V. J. (2022). The pathophysiology of Staphylococcus aureus abscess formation. Frontiers in Cellular and Infection Microbiology, 12, 1040274. https://doi.org/10.3389/fcimb.2022.1040274

Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., ... & Duffy, J. (2019). Vital signs: Epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. Morbidity and Mortality Weekly Report, 68(9), 214–219. https://doi.org/10.15585/mmwr.mm6809e1 DOI: https://doi.org/10.15585/mmwr.mm6809e1

Powers, M. E., & Wardenburg, J. B. (2023). From colonization to cytotoxicity: Staphylococcus aureus at the host-pathogen interface. Annual Review of Pathology: Mechanisms of Disease, 18, 123–145. https://doi.org/10.1146/annurev-pathmechdis-031521-042754 DOI: https://doi.org/10.1146/annurev-pathmechdis-031521-042754

Shukla, S. K., Ramaswamy, S. V., & Conradt, J. (2020). The role of MSCRAMMs in the pathogenesis of Staphylococcus aureus infections. Microorganisms, 8(6), 832. https://doi.org/10.3390/microorganisms8060832 DOI: https://doi.org/10.3390/microorganisms8060832

Spaan, A. N., van Strijp, J. A. G., & Torres, V. J. (2023). Leukocidins: Staphylococcal bi-component pore-forming toxins find their receptors. Nature Reviews Microbiology, 21(11), 755–769. https://doi.org/10.1038/s41579-023-00923-0 DOI: https://doi.org/10.1038/s41579-023-00923-0

Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., ... & Fowler, V. G. (2019). Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nature Reviews Microbiology, 17(4), 203–218. https://doi.org/10.1038/s41579-018-0147-4 DOI: https://doi.org/10.1038/s41579-018-0147-4

Zorgani, A., Abdulrazeg, F., Shawerf, O., Tawil, K., Alzerj, A., & Ghenghesh, K. S. (2019). Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary-care hospital in Misurata, Libya. Journal of Infection in Developing Countries, 13(12), 1086–1092. https://doi.org/10.3855/jidc.11844

• pdf

Copyright (c) 2025 Fatalla Merjan Daboos, Eisa S Omar, Osama Muftah Ahmed (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.